Amiodarone: review of pulmonary effects and toxicity

SA Papiris, C Triantafillidou, L Kolilekas, D Markoulaki… - Drug safety, 2010 - Springer
… [36] The extensive tissue binding of amiodarone results in a pharmacokinetic profile with
a high volume of drug distribution (V d = 5000 L) and an extremely long elimination half-life (t½ …

Control of asthma in real life: still a valuable goal?

…, K Kostikas, E Zervas, L Kolilekas… - European …, 2015 - Eur Respiratory Soc
Although studies show that control of asthma can be achieved in the majority of patients,
surveys repeatedly show that this is not the case in real life. Important measures to implement in …

[HTML][HTML] Clinical review: idiopathic pulmonary fibrosis acute exacerbations-unravelling Ariadne's thread

SA Papiris, ED Manali, L Kolilekas, K Kagouridis… - Critical Care, 2010 - Springer
Idiopathic pulmonary fibrosis (IPF) is a dreadful, chronic, and irreversibly progressive fibrosing
disease leading to death in all patients affected, and IPF acute exacerbations constitute …

Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis

L Kolilekas, E Manali, KA Vlami… - Journal of Clinical …, 2013 - jcsm.aasm.org
Kolilekas and Manali contributed equally to this work. This work has been supported by the
Kolilekas has been the primary investigator, participated in clinical and laboratory evaluation …

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations

…, A Spathis, I Korbila, A Analitis, L Kolilekas… - Cytokine, 2018 - Elsevier
Introduction Controversy exists about the pathogenesis of idiopathic pulmonary fibrosis acute
exacerbations (IPF-AEs). According to one hypothesis IPF-AEs represent the development …

Can steroids reverse the severe COVID‐19 induced “cytokine storm”?

L Kolilekas, K Loverdos, S Giannakaki… - Journal of medical …, 2020 - Wiley Online Library
… Lykourgos Kolilekas and Konstantinos Loverdos contributed equally to this work. … alanine
aminotransferase, 60.5; range, 17-343 IU/L) were noticed in four patients. CRP and ferritin in …

[HTML][HTML] MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a …

…, P Lyberopoulos, C Triantafillidou, LF Kolilekas… - BMC pulmonary …, 2010 - Springer
Background Exertional dyspnea is the most prominent and disabling feature in idiopathic
pulmonary fibrosis (IPF). The Medical Research Chronic (MRC) chronic dyspnea score as well …

[HTML][HTML] Survival in idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach

SA Papiris, K Kagouridis, L Kolilekas… - BMC pulmonary …, 2015 - Springer
Background Idiopathic pulmonary fibrosis acute exacerbation (IPF-AE) constitutes IPF’s
most devastating event, representing the unexpected superimposition of diffuse alveolar …

Lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective multicentre study in Europe

…, F Bonella, N Kahn, L Kolilekas, E Rosi, L Gori… - …, 2023 - Wiley Online Library
Background and Objective There remains a paucity of large databases for patients with
idiopathic pulmonary fibrosis (IPF) and lung cancer. We aimed to create a European registry. …

[HTML][HTML] Acute severe asthma: new approaches to assessment and treatment

SA Papiris, ED Manali, L Kolilekas, C Triantafillidou… - Drugs, 2009 - Springer
The precise definition of a severe asthmatic exacerbation is an issue that presents difficulties.
The term ‘status asthmaticus’ relates severity to outcome and has been used to define a …